Selected article for: "lethal infection and MVA immunization"

Author: Kremer, Melanie; Suezer, Yasemin; Volz, Asisa; Frenz, Theresa; Majzoub, Monir; Hanschmann, Kay-Martin; Lehmann, Michael H.; Kalinke, Ulrich; Sutter, Gerd
Title: Critical Role of Perforin-dependent CD8+ T Cell Immunity for Rapid Protective Vaccination in a Murine Model for Human Smallpox
  • Document date: 2012_3_1
  • ID: 0mmtcbof_17
    Snippet: Rapidly protective MVA immunization in the absence of B cells Previous work had already indicated that adaptive immunity contributes to MVA-induced protection against lethal ECTV infection [41] . Furthermore, passive immunization with vaccinia immune globulin around the day of infection fully protects mice against lethal mousepox [53] , indicating that antibodies are the important players in adaptive immunity. Indeed, we showed above that specifi.....
    Document: Rapidly protective MVA immunization in the absence of B cells Previous work had already indicated that adaptive immunity contributes to MVA-induced protection against lethal ECTV infection [41] . Furthermore, passive immunization with vaccinia immune globulin around the day of infection fully protects mice against lethal mousepox [53] , indicating that antibodies are the important players in adaptive immunity. Indeed, we showed above that specific antibodies are found in the respiratory tract early after intranasal inoculation with MVA ( Figure 1D ). To further analyze the role of antibody responses we performed experiments to assess the rapid protective capacity of MVA vaccination in RAG-1 2/2 mice lacking mature T and B cells, and in B cell-deficient mMT mice [54] . Confirming previous data, vaccinated RAG-1 2/2 mice ( Figure 3A ) all succumbed to the ECTV challenge infection, confirming the importance of adaptive responses in rapid protection. However, MVA immunization robustly protected B cell-deficient mice from disease and death ( Figure 3B ; P,0.0001).

    Search related documents:
    Co phrase search for related documents
    • adaptive immunity and challenge infection: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • adaptive immunity and death disease: 1, 2, 3, 4, 5, 6, 7
    • adaptive immunity and ECTV infection: 1
    • adaptive immunity and infection day: 1, 2
    • adaptive immunity and intranasal inoculation: 1, 2
    • adaptive immunity contribute and death disease: 1
    • adaptive response and antibody response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • adaptive response and challenge infection: 1, 2, 3, 4
    • adaptive response and death disease: 1, 2, 3
    • adaptive response and infection day: 1, 2, 3
    • antibody response and cell deficient mouse: 1
    • antibody response and challenge infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • antibody response and death disease: 1, 2, 3, 4, 5, 6, 7
    • antibody response and ECTV infection: 1
    • antibody response and infection day: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • antibody response and intranasal inoculation: 1, 2, 3
    • challenge infection and death disease: 1, 2, 3, 4, 5
    • challenge infection and ECTV challenge infection: 1, 2, 3, 4
    • challenge infection and ECTV infection: 1, 2, 3, 4, 5, 6